Final Program

MONDAY • MAY 16 149
414 Spirometric Trajectories in Lung Disease Longitudinal
Surveillance of Former Workers and Volunteers at the World
Trade Center Disaster Site/R.E. de la Hoz, L.A. Bienenfeld, J.T.
Doucette, S. Zafar, D.A. Carson, S. Luna-Sanchez, New York, NY,
p.A3002
415 Is the Cardiopulmonary Exercise Testing Better than
Spirometry to Detect Early Ventilatory Changes Related to
Occupational Exposure to Particulate Matter?/V.Z. Dourado,
E.F. Sperandio, C.T. Ping, M. Romiti, A. Gagliardi, R. Arantes,
Santos, Brazil, p.A3003
416 Occupational Microbial Exposures of Animal Care Workers
Measured by 16S rDNA Sequencing/P.S. Lai, J.G. Allen, T.
Winters, C.M. North, C. Hug, J. Vallarino, D.C. Christiani, Boston,
MA, p.A3004
417 Exposure to High Endotoxin Concentration Increases
Wheezing Prevalence Among Laboratory Animal Workers/E.O.
Vianna, A.S. Freitas, C.S. Simoneti, E. Ferraz, M.C. Borges,
Ribeirao Preto, Brazil, p.A3005
418 The Effects of Pulmonary Clearance Associated with Radiation
Injury to the Lung: Comparison of Newborn Mice and Adult
Mice/C. Johnston, J.P. Williams, R. Gelein, E. Hernady, C. Reed,
J.N. Finkelstein, Rochester, NY, p.A3006
419 Reduced Lung Function in Children Associated with
137Cesium Body Burden/E.R. Svendsen, I.E. Kolpakov, W.J.J.
Karmaus, L. Mohr, V.Y. Vdovenko, D.M. McMahon, B.A. Jelin, Y.I.
Stepanova, Charleston, SC, p.A3007
420 Comparing Plasma, Serum, and Whole Blood Indium
Concentrations from Workers at an Indium-Tin Oxide (ITO)
Production Facility/R.R. Harvey, M.A. Virji, N.T. Edwards, K.
Cummings, Morgantown, WV, p.A3008
421 5-ASA Treatment in Chronic Beryllium Disease/L.A. Maier, B.
Barkes, M. Gillespie, J. Elliott, G. Mondello, J. Huang, B. Day,
Denver, CO, p.A3009
422 The Role of JAK2 in Chronic Beryllium Disease/L. Li, N.
Hamzeh, M. Gillespie, G. Mondello, P.M. Mroz, L. Maier, Denver,
CO, p.A3010
423 Particle Matter (PM) Accumulation in Airways of Dental
Technicians (DT) Exposed to Beryllium Is a Sensitive
Biomarker to Reveal Early Cellular and Molecular
Changes/E.M. Fireman, Y. Lerman, L.A. Maier, L. Newman, M.
Stark, Tel Aviv, Israel, p.A3011
424 Development of Pulmonary Fibrosis Following Bromine
Inhalation Injury/A. Lam, S. Aggarwal, M.A. Carlisle, N. Vetal, A.
Agarwal, S. Matalon, Birmingham, AL, p.A3012
425 Increased Risk of Pneumonia in Residents Living near Poultry
Farms: Does the Upper Respiratory Tract Microbiota Play a
Role?/L.A.M. Smit, G.J. Boender, W.A.A. De Steenhuijsen Piters,
T.J. Hagenaars, E.G.W. Huijskens, J.W.A. Rossen, M. Koopmans,
G. Nodelijk, E.A.M. Sanders, J. Yzermans, D. Bogaert, D.
Heederik, Utrecht, Netherlands, p.A7806
B25
POSTER DISCUSSION SESSION
NON-TUBERCULOUS MYCOBACTERIA:
EPIDEMIOLOGY, DIAGNOSIS, AND TREATMENT
9:00 a.m. - 11:00 a.m. MOSCONE CENTER
Room 3014 (West Building, Level 3)
Poster Viewing 9:00-9:45
Discussion 9:45-11:00
Chairing: K.L. Winthrop, MD, MPH, Portland, OR
T.R. Aksamit, MD, Rochester, MN
C. Swenson, MD, Atlanta, GA
901 Epidemiology of Nontuberculous Mycobacterial Lung Disease in
Hawaii/J. Adjemian, T.B. Frankland, Y.G. Daida, J.R. Honda, K.N.
Olivier, A. Zelazny, S. Honda, D.R. Prevots, Bethesda, MD, p.A3013
902 Prevalence of Nontuberculous Mycobacterial Infections
Among Patients at 151 US Hospitals, 2009-2013/A.B. Spaulding,
Y.L. Lai, K.N. Olivier, A. Zelazny, S.S. Kadri, D.R. Prevots, J.
Adjemian, Bethesda, MD, p.A3014
903 Prevalence of Nontuberculous Mycobacterium in HIV Patients
Admitted with Pneumonia/N.C. Lapinel, S.E. Jolley, J. Ali, D.A.
Welsh, New Orleans, LA, p.A3015
904 Clinical Significance of Nontuberculous Mycobacteria Isolated
from Respiratory Specimens in a Chinese Tuberculosis
Tertiary Care Center/H. Duan, N. Chu, Beijing, China, p.A3016
905 Circulating Exosome and Sputum Pofiling of Women with
Nontuberculous Mycobacterial Disease and Breast Cancer/J.V.
Philley, A. Kannan, J.L. Benwill, D.E. Griffith, B.A. Brown-Elliott, F.
Thakkar, H.K. Bains, M.S. Devine, R.J. Wallace, S. Dasgupta,
Tyler, TX, p.A3017
906 Northwest Biorepository of Nontuberculous Mycobacteria
Patients- Baseline Characteristics/E. Henkle, S. Novosad, S.A.R.
Siegel, C.D. Varley, A. Stadnik, K.L. Winthrop, Portland, OR,
p.A3018
907 Long Term Quality of Life After Nontuberculous Mycobacteria
Infection/E. Henkle, S. Novosad, S.A.R. Siegel, K.L. Winthrop,
Portland, OR, p.A3019
908 Nontuberculous Mycobacterial Lung Infections After Allogenic
Hematopoietic Stem Cell Transplantation: Incidence,
Characteristics and Outcomes/J. Beswick, D. Kim, T.K. Marras,
Toronto, Canada, p.A3020
909 Nontuberculous Mycobacteria Drug Susceptibilities in Ontario,
Canada, 2010 - 2015/F.B. Jamieson, E. Andrews, A.
Marchand-Austin, M. Sharma, S.K. Brode, T.K. Marras, Toronto,
Canada, p.A3021
910 Macrolide Susceptible Mycobacterium Abscessus Lung
Infections/J.L. Benwill, J.V. Philley, B.A. Brown-Elliott, D.E. Griffith,
R.J. Wallace, Tyler, TX, p.A3022
911 The Usefulness of Radiological Severity Score in Patients with
Mycobacterium Avium Complex Lung Disease/K. Furuuchi, A.
Ito, T. Hashimoto, S. Kumagai, T. Ishida, Kurashiki, Okayama,
Japan, p.A3023
MONDAY MORNING
ATS 2016 • San Francisco